Insider Trading June 23, 2026 09:23 PM

Japan Post Holdings Divests $3.25 Million in Aflac Shares Amid Trading Near 52-Week High

Major shareholder reduces position as insurer reports mixed Q1 results and expands operational footprint in Maine.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
AFL

Japan Post Holdings Co., Ltd. has executed a sale of Aflac Inc. common stock valued at approximately $3.25 million on June 22, 2026. The transaction reduces the indirect ownership stake of the Japanese financial conglomerate, which currently holds over 50 million shares through a trust structure. The sale occurs as Aflac's stock trades near its 52-week high, reflecting recent corporate developments including a strong revenue beat in the first quarter of 2026 and operational expansion in Maine.

Japan Post Holdings Divests $3.25 Million in Aflac Shares Amid Trading Near 52-Week High
AFL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Japan Post Holdings sold 27,845 shares of Aflac across two transactions on June 22, 2026, reducing its indirect ownership stake.
  • Aflac reported Q1 2026 revenue of $4.35 billion, beating estimates, though adjusted EPS of $1.75 missed the $1.80 forecast.
  • The insurer has expanded operations with a new office in South Portland, Maine, to manage the state’s Paid Family and Medical Leave program.

Japan Post Holdings Co., Ltd., a significant 10% shareholder in Aflac Inc. (NYSE:AFL), has executed a divestment of Aflac common stock totaling approximately $3.25 million. The reported transactions took place on June 22, 2026, and involved two distinct sales events that reduced the entity's indirect holdings in the insurer.

According to the filing details, the first transaction involved the disposal of 23,416 shares. These shares were sold at a weighted average price of $116.57 per share. The execution of this portion of the sale occurred across multiple transactions, with prices ranging from $116.18 to $117.18 per share. A second, separate transaction followed, seeing the sale of an additional 4,429 shares. This second block was sold at a weighted average price of $117.46 per share, with individual transaction prices ranging from $117.20 to $117.72 per share.

The divestment occurs as Aflac shares trade near their 52-week high of $119.81. At the time of reporting, the stock was valued at $118.79. Analysis from InvestingPro indicates that the stock is trading close to its Fair Value. The insurer has delivered an 8.9% return year-to-date and maintains a dividend yield of 2.05%, having raised its dividend for 42 consecutive years.

Following these sales, Japan Post Holdings indirectly holds 50,898,490 shares of Aflac common stock. The reported securities are held directly by J&A Alliance Holdings Corporation, acting as the trustee of the J&A Alliance Trust. Japan Post Holdings Co., Ltd. is the sole settlor and beneficiary of this Trust, which establishes its deemed beneficial ownership of the shares.

In parallel corporate developments, Aflac Incorporated reported its first-quarter 2026 earnings, highlighting a notable revenue achievement. The company recorded $4.35 billion in revenue, surpassing the forecast of $4.18 billion. However, Aflac’s adjusted earnings per share (EPS) came in at $1.75, slightly below the anticipated $1.80. These financial results reflect a mixed performance, with strong revenue but an EPS miss.

Additionally, shareholders recently approved all company proposals at the annual meeting, except for a measure seeking an independent board chairman. Eleven directors were elected to the board, and KPMG LLP was ratified as the independent registered public accounting firm until the end of 2026. In another development, Aflac opened a new office in South Portland, Maine, to manage the state’s Paid Family and Medical Leave program. This facility will handle claims administration for over 500,000 eligible workers and participating employers in Maine.

Market data for Aflac shows the stock closed at 118.79, up +2.24 (+1.92%). After-hours trading saw the stock at 118.99, up +0.20 (+0.17%). The stock has shown a 1D, 1W, 1M, 6M, 1Y, 5Y, and Max performance chart, indicating its trading history.

Investors seeking deeper insights into Aflac’s valuation and performance can access the comprehensive Pro Research Report, available for this and 1,400+ other US equities.

Risks

  • Aflac's adjusted earnings per share missed analyst expectations, indicating potential pressure on profitability metrics despite revenue growth.
  • Shareholders rejected a proposal for an independent board chairman, highlighting possible governance dynamics within the company.

More from Insider Trading

ConnectM CFO Choudhury Accumulates Shares Ahead of Sharp Price Rally Jun 23, 2026 ConnectM CEO Increases Holdings Amid Market Volatility Jun 23, 2026 Spyre Therapeutics Director-Affiliated Fund Liquidates Nearly $400 Million Stake Jun 23, 2026 Spyre Therapeutics Director Henderson Offloads $2 Million in Equity Under Pre-Arranged Plan Jun 23, 2026 Crescent Biopharma CFO Sells Shares to Cover Tax Obligations Amid Clinical Developments Jun 23, 2026